Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06743295

AI Noise Reduction in Phonak Hearing Aids

Evaluation of Artificial Intelligence Based Noise Reduction in Phonak Hearing Aid on Patients With Hearing Impairment and Cochlear Implants

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
500 (estimated)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years – 110 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if artificial intelligence- based noise reduction can offer objective improvement in hearing and speech perception for hearing impaired patients.

Conditions

Interventions

TypeNameDescription
DEVICEDEEPSONIC™ Deep Sound Optimized Neural Integrated Chip Artificial intelligence-based noise reductionParticipants with hearing loss will be fitted with the Phonak Audéo Sphere™ Infinio (PAI) hearing aid with artificial intelligence (AI)-based noise reduction, which incorporates deep neural networks (DNN) technology to reduce background noise. Speech stimuli, presented at a comfortable level of approximately 60 dB SPL (like normal conversation), will be delivered via a loudspeaker positioned directly in front of the participant. They will be tested in 3 listening environments: quiet, moderate noise, high noise. Speech perception scores will be measured as a function of each hearing aid program setting: quiet setting, moderate noise, and advanced AI-based reduction for high noise.

Timeline

Start date
2025-04-24
Primary completion
2027-01-01
Completion
2027-01-01
First posted
2024-12-19
Last updated
2026-02-06

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06743295. Inclusion in this directory is not an endorsement.